|
US8221761B1
(en)
*
|
1999-02-26 |
2012-07-17 |
Novartis Ag |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifs
|
|
BR0010130A
(pt)
*
|
1999-04-30 |
2002-06-04 |
Chiron Spa |
Antìgenos de neisseria conservados
|
|
CN102580072A
(zh)
*
|
1999-05-19 |
2012-07-18 |
诺华疫苗和诊断有限公司 |
组合式奈瑟球菌组合物
|
|
PT1947187E
(pt)
|
2000-02-28 |
2011-07-04 |
Novartis Vaccines & Diagnostic |
Expressões híbridas de proteínas de neisseria
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
EP2258386A3
(de)
*
|
2002-08-02 |
2011-11-02 |
GlaxoSmithKline Biologicals S.A. |
Neisseria Impfstoffzusammensetzung
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
NZ562998A
(en)
*
|
2002-10-11 |
2008-05-30 |
Novartis Vaccines & Diagnostic |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
|
ATE466875T1
(de)
|
2002-11-15 |
2010-05-15 |
Novartis Vaccines & Diagnostic |
Unerwartete oberflächenproteine in neisseria meningitidis
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
|
GB0315021D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Chiron Srl |
Immunogenic gonococcal compositions
|
|
JP4625019B2
(ja)
*
|
2003-12-19 |
2011-02-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
ナイセリア・ゴノロエアエ検出のための試薬および方法
|
|
JP5173194B2
(ja)
*
|
2003-12-23 |
2013-03-27 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
GB0404374D0
(en)
*
|
2004-02-27 |
2004-03-31 |
Univ Manchester |
Treatment of bacterial infections
|
|
US7357932B2
(en)
*
|
2004-06-16 |
2008-04-15 |
Center Of Disease Control Department Of Health |
Surface protein of Neisseria bacteria
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
US8329884B2
(en)
|
2004-12-17 |
2012-12-11 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
|
EP2298795A1
(de)
|
2005-02-18 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogene von uropathogenen E. coli
|
|
HUE027400T2
(en)
|
2005-02-18 |
2016-10-28 |
Glaxosmithkline Biologicals Sa |
Proteins and nucleic acids from meningitis / sepsis with Escherichia coli
|
|
EP1723964A1
(de)
*
|
2005-05-20 |
2006-11-22 |
Institut Pasteur |
Verwendung von Penicillin-bindenden Proteinen, Polynukleotiden oder dagegen gerichteten Antikörpern zur Vorbeugung oder Behandlung von bakteriellen Infektionen
|
|
GB0513096D0
(en)
|
2005-06-28 |
2005-08-03 |
Strathclyde |
Treatment of microbial infections
|
|
KR20080042804A
(ko)
|
2005-07-19 |
2008-05-15 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
뇌혈관장벽을 통하여 뇌 암세포 내로 침투하는 운반제 및이의 이용 방법
|
|
WO2007047749A1
(en)
|
2005-10-18 |
2007-04-26 |
Novartis Vaccines And Diagnostics Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
|
WO2007081447A2
(en)
|
2005-11-22 |
2007-07-19 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
CU23549A1
(es)
*
|
2005-12-29 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Composiciones farmacéuticas que contienen la proteína nma0939
|
|
US8173657B2
(en)
|
2006-03-23 |
2012-05-08 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
CU23575A1
(es)
*
|
2006-03-31 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Composición farmacéutica que comprende la proteína nmb0606
|
|
ES2366798T3
(es)
*
|
2006-05-29 |
2011-10-25 |
Bio-Rad Pasteur |
Detección múltiple en tiempo real de tres especies bacterianas responsables de enfermedades de transmisión sexual.
|
|
US8039007B2
(en)
|
2006-06-29 |
2011-10-18 |
J. Craig Venter Institute, Inc. |
Polypeptides from Neisseria meningitidis
|
|
JP2010500399A
(ja)
|
2006-08-16 |
2010-01-07 |
ノバルティス アーゲー |
尿路病原性大腸菌由来の免疫原
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
CN101743251A
(zh)
*
|
2007-03-26 |
2010-06-16 |
联邦科学技术研究组织 |
具有抗真菌活性的肽
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
JP5653215B2
(ja)
|
2007-09-12 |
2015-01-14 |
ノバルティス アーゲー |
Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
|
|
CN101977926B
(zh)
|
2007-12-21 |
2014-10-08 |
诺华股份有限公司 |
链球菌溶血素o的突变形式
|
|
CN102066404B
(zh)
*
|
2008-04-23 |
2013-11-13 |
诺娃细胞科技公司 |
血管生成肽
|
|
US8188250B2
(en)
*
|
2008-04-28 |
2012-05-29 |
Butamax(Tm) Advanced Biofuels Llc |
Butanol dehydrogenase enzyme from the bacterium Achromobacter xylosoxidans
|
|
TWI466680B
(zh)
|
2008-08-01 |
2015-01-01 |
Oncotherapy Science Inc |
Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
|
|
US20110182981A1
(en)
*
|
2008-08-25 |
2011-07-28 |
Peixuan Zhu |
Gonococcal vaccines
|
|
AU2009287339B2
(en)
*
|
2008-08-28 |
2015-11-26 |
The University Of Queensland |
Mutant bacterial glycoproteins and uses thereof
|
|
MX2011007456A
(es)
|
2009-01-12 |
2011-08-03 |
Novartis Ag |
Antigenos del dominio de proteina de superficie de union a colageno tipo b (can_b) en vacunas contra bacteria gram positiva.
|
|
AU2010258677B2
(en)
|
2009-06-10 |
2016-10-06 |
Glaxosmithkline Biologicals S.A. |
Benzonaphthyridine-containing vaccines
|
|
EP2443250B8
(de)
|
2009-06-16 |
2016-09-21 |
GlaxoSmithKline Biologicals SA |
Komplement-vermittelte antikörper-abhängige und opsonische bakterienassays mit hohem durchlauf
|
|
WO2011026111A1
(en)
|
2009-08-31 |
2011-03-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Oral delivery of a vaccine to the large intestine to induce mucosal immunity
|
|
SG178954A1
(en)
|
2009-09-02 |
2012-04-27 |
Novartis Ag |
Immunogenic compositions including tlr activity modulators
|
|
JO3257B1
(ar)
|
2009-09-02 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات كمعدلات لفاعلية tlr
|
|
JP5875518B2
(ja)
*
|
2009-09-24 |
2016-03-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
膀胱がん特異的なリガンドペプチド
|
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
|
SG10201501980SA
(en)
|
2009-12-15 |
2015-05-28 |
Novartis Ag |
Homogeneous suspension of immunopotentiating compounds and uses thereof
|
|
TWI485245B
(zh)
|
2010-01-25 |
2015-05-21 |
Oncotherapy Science Inc |
經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
|
|
DK2542257T3
(en)
|
2010-03-01 |
2017-10-16 |
Bayer Healthcare Llc |
OPTIMIZED MONOCLONAL ANTIBODIES AGAINST Tissue FACTOR ROAD INHIBITOR (TFPI)
|
|
EP2549990A1
(de)
|
2010-03-23 |
2013-01-30 |
Irm Llc |
Verbindungen (cysteinbasierte lipopeptide) und zusammensetzungen als tlr2-agonisten zur behandlung von infektionen, entzündungen, atemwegserkrankungen etc.
|
|
CA2795403C
(en)
|
2010-04-08 |
2019-01-15 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
B-cell antigen presenting cell assay
|
|
CN102933267B
(zh)
|
2010-05-28 |
2015-05-27 |
泰特里斯在线公司 |
交互式混合异步计算机游戏基础结构
|
|
PL3246044T5
(pl)
|
2010-08-23 |
2024-06-17 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
|
ES2728282T3
(es)
|
2010-09-10 |
2019-10-23 |
Wyeth Llc |
Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
|
|
GB201102090D0
(en)
*
|
2011-02-08 |
2011-03-23 |
Univ Sheffield |
Antigenic polypeptide
|
|
GB201120634D0
(en)
*
|
2011-11-30 |
2012-01-11 |
Univ Sheffield |
Adjuvant polypeptide
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
RU2665841C2
(ru)
|
2012-03-09 |
2018-09-04 |
Пфайзер Инк. |
Композиции neisseria meningitidis и способы их применения
|
|
GB201211154D0
(en)
*
|
2012-06-22 |
2012-08-08 |
Univ Southampton |
Composition
|
|
CA2875391A1
(en)
|
2012-07-27 |
2014-01-30 |
Institut National De La Sante Et De La Recherche Medicale |
Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
|
|
CA2891552A1
(en)
*
|
2012-11-16 |
2014-05-22 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Gonorrheal mtre peptides and vaccines
|
|
BR112015018014A2
(pt)
|
2013-02-01 |
2017-07-11 |
Glaxosmithkline Biologicals Sa |
liberação intradérmica de composições imunológicas compreendendo agonistas do receptor do tipo toll
|
|
CA2903716C
(en)
|
2013-03-08 |
2019-04-09 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
CA2906373C
(en)
*
|
2013-03-15 |
2023-03-28 |
Becton, Dickinson And Company |
Detection of neisseria gonorrhoeaes
|
|
US9725701B2
(en)
|
2013-03-15 |
2017-08-08 |
Iowa Corn Promotion Board |
Prokarytoic-type isocitrate dehydrogenase and its application for improving nitrogen utilization in transgenic plants
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
GB201319180D0
(en)
*
|
2013-10-30 |
2013-12-11 |
Mast Group Ltd |
Nucleic acid probe
|
|
GB201416459D0
(en)
*
|
2014-09-17 |
2014-10-29 |
Atlas Genetics Ltd |
Detection method
|
|
RU2723045C2
(ru)
|
2015-02-19 |
2020-06-08 |
Пфайзер Инк. |
Композиции neisseria meningitidis и способы их получения
|
|
CN104673791A
(zh)
*
|
2015-03-10 |
2015-06-03 |
普生（天津）科技有限公司 |
淋球菌ng的特异dna序列
|
|
EP3287468B1
(de)
*
|
2015-04-23 |
2020-09-16 |
BGI Shenzhen |
Zwei conotoxinpeptide, herstellungsverfahren dafür und anwendungen davon
|
|
CN108885212B
(zh)
|
2016-02-22 |
2022-05-31 |
勃林格殷格翰维特梅迪卡有限公司 |
固定生物分子的方法
|
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
SE541618C2
(en)
*
|
2017-02-24 |
2019-11-12 |
Biotome Pty Ltd |
Novel peptides and their use in diagnosis
|
|
SG11202007688YA
(en)
|
2018-02-12 |
2020-09-29 |
Inimmune Corp |
Toll-like receptor ligands
|
|
US10450616B1
(en)
|
2018-05-09 |
2019-10-22 |
Talis Biomedical Corporation |
Polynucleotides for the amplification and detection of Chlamydia trachomatis
|
|
US20220081707A1
(en)
*
|
2018-07-25 |
2022-03-17 |
The Trustees Of Indiana University |
Diagnostic assay for a strain of neisseria meningitidis
|
|
WO2020086408A1
(en)
|
2018-10-26 |
2020-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
A high-yield perfusion-based transient gene expression bioprocess
|
|
SG11202106494RA
(en)
*
|
2018-12-21 |
2021-07-29 |
Univ Griffith |
Compositions, methods and uses for eliciting an immune response
|
|
US10954572B2
(en)
*
|
2019-07-25 |
2021-03-23 |
Talis Biomedical Corporation |
Polynucleotides for the amplification and detection of Neisseria gonorrhoeae
|
|
US20220280630A1
(en)
*
|
2019-08-01 |
2022-09-08 |
Trustees Of Tufts College |
Vaccine compositions and methods of selecting antigens
|
|
US11891662B2
(en)
|
2019-12-02 |
2024-02-06 |
Talis Biomedical Corporation |
Polynucleotides for amplification and detection of human beta actin
|
|
WO2021140123A1
(en)
*
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
|
IL302449A
(en)
|
2020-11-04 |
2023-06-01 |
Eligo Bioscience |
CUTIBACTERIUM ACNES PHAGES RECOMBINANT, the production method and their uses
|
|
CA3224564A1
(en)
*
|
2021-07-05 |
2023-01-12 |
Andreas Holm MATTSSON |
Vaccines targeting neisseria gonorrhoeae
|
|
CA3237085A1
(en)
*
|
2021-11-11 |
2023-05-19 |
Frederic Veyrier |
Endonucleases that selectively cleave single-stranded nucleic acids and uses thereof
|